|
|
Volumn 88, Issue 12, 2001, Pages 1403-1406
|
|
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DESULFATOHIRUDIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOLYTIC AGENT;
GLYCOPROTEIN IIB;
GLYCOPROTEIN IIIA;
HEPARIN;
HIRULOG;
RECOMBINANT HIRUDIN;
STREPTOKINASE;
THIENNOPYRIDINE;
THROMBIN INHIBITOR;
UNCLASSIFIED DRUG;
ANGIOPLASTY;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG INFUSION;
FEMALE;
HEART CATHETERIZATION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVASCULARIZATION;
RISK;
ST SEGMENT ELEVATION;
T WAVE;
THORAX PAIN;
THROMBOPLASTIN TIME;
TREATMENT OUTCOME;
AGED;
ANGINA, UNSTABLE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
FEMALE;
HEART CATHETERIZATION;
HEPARIN;
HIRUDIN THERAPY;
HIRUDINS;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
RECOMBINANT PROTEINS;
RECURRENCE;
SYNDROME;
|
|
EID: 0035893374
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)02119-1 Document Type: Article |
|
Times cited : (29)
|
|
References (11)
|
